Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-12-008234
Filing Date
2012-08-13
Accepted
2012-08-13 06:04:57
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q govx_10q-063012.htm 10-Q 463504
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 16564
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 16503
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 6395
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 6663
  Complete submission text file 0001437749-12-008234.txt   2519502

Data Files

Seq Description Document Type Size
6 govx-20120630.xml EX-101.INS 251419
7 govx-20120630.xsd EX-101.SCH 29472
8 govx-20120630_cal.xml EX-101.CAL 22591
9 govx-20120630_def.xml EX-101.DEF 145423
10 govx-20120630_lab.xml EX-101.LAB 205972
11 govx-20120630_pre.xml EX-101.PRE 148396
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 121025944
SIC: 8731 Services-Commercial Physical & Biological Research